SMT201600171B - Sale e solvati di un derivato di tetraidro-isochinolina - Google Patents

Sale e solvati di un derivato di tetraidro-isochinolina

Info

Publication number
SMT201600171B
SMT201600171B SM201600171T SM201600171T SMT201600171B SM T201600171 B SMT201600171 B SM T201600171B SM 201600171 T SM201600171 T SM 201600171T SM 201600171 T SM201600171 T SM 201600171T SM T201600171 B SMT201600171 B SM T201600171B
Authority
SM
San Marino
Prior art keywords
solvati
tetraidro
isochinolin
derivative
salt
Prior art date
Application number
SM201600171T
Other languages
English (en)
Inventor
Thomas David Mccarthy
Peter Michael Kelly
Craig James Stewart Boyle
Alexander Redvers Eberlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SMT201600171B publication Critical patent/SMT201600171B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SM201600171T 2010-07-21 2016-06-15 Sale e solvati di un derivato di tetraidro-isochinolina SMT201600171B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36636710P 2010-07-21 2010-07-21
PCT/GB2011/001096 WO2012010843A1 (en) 2010-07-21 2011-07-21 Salt and solvates of a tetrahydroisoquinoline derivative

Publications (1)

Publication Number Publication Date
SMT201600171B true SMT201600171B (it) 2016-07-01

Family

ID=44386640

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600171T SMT201600171B (it) 2010-07-21 2016-06-15 Sale e solvati di un derivato di tetraidro-isochinolina

Country Status (20)

Country Link
US (3) US8614227B2 (it)
EP (2) EP2595960B1 (it)
JP (3) JP5948326B2 (it)
CN (2) CN103003244B (it)
AU (3) AU2011281381B2 (it)
CA (1) CA2803699C (it)
DK (1) DK2595960T3 (it)
ES (1) ES2570135T3 (it)
HK (1) HK1224290A1 (it)
HR (1) HRP20160540T1 (it)
HU (1) HUE028620T2 (it)
ME (1) ME02407B (it)
NZ (2) NZ605444A (it)
PL (1) PL2595960T3 (it)
PT (1) PT2595960E (it)
RS (1) RS54789B1 (it)
SI (1) SI2595960T1 (it)
SM (1) SMT201600171B (it)
WO (1) WO2012010843A1 (it)
ZA (1) ZA201300169B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ605444A (en) * 2010-07-21 2015-06-26 Spinifex Pharm Pty Ltd Salt and solvates of a tetrahydroisoquinoline derivative
US9320530B2 (en) * 2013-03-13 2016-04-26 The Spectranetics Corporation Assisted cutting balloon
NZ630908A (en) * 2013-07-08 2017-08-25 Novartis Ag Heterocyclic compounds and methods of their use
CN107001337B (zh) 2015-01-13 2021-05-04 诺华股份有限公司 作为血管紧张素ii型拮抗剂的吡咯烷衍生物
ES2898635T3 (es) 2015-03-12 2022-03-08 Novartis Ag Compuestos heterocíclicos y métodos para su uso
CN106478502B (zh) * 2015-08-29 2021-04-27 上海翰森生物医药科技有限公司 1,2,3,4-四氢异喹啉衍生物、其制备方法和应用
EP3475261A1 (en) 2016-06-27 2019-05-01 ratiopharm GmbH Crystalline calcium salt of (s)-2-(diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid
WO2018172950A1 (en) * 2017-03-23 2018-09-27 Novartis Ag Anhydrous crystalline forms of sodium (s)-2-(diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinolinecarboxylate
KR102132761B1 (ko) * 2017-06-09 2020-07-17 산동 단홍 파머수티컬 컴퍼니., 리미티드. At2r 수용체 길항제로서의 카르복시산 유도체
WO2020012266A1 (en) 2018-07-12 2020-01-16 Novartis Ag Biocatalytic synthesis of olodanrigan (ema401) from 3-(2-(benzyloxy)-3-methoxyphenyl)propenoic acid with phenylalanine ammonia lyase
EP3820833A4 (en) 2018-07-12 2022-08-03 Codexis, Inc. MODIFIED AMMONIA-LYASE PHENYLALANINE POLYPEPTIDES
CN111620816B (zh) * 2020-05-27 2023-06-02 上海赛默罗生物科技有限公司 螺桨烷类衍生物、其制备方法、药物组合物和用途
GB202100352D0 (en) * 2021-01-12 2021-02-24 Balticgruppen Bio Ab New methods
CN115901740A (zh) * 2022-11-18 2023-04-04 南京工业大学 基于Pictet-Spengler反应的多巴胺检测试剂及应用、多巴胺的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246943A (en) 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
US5236934A (en) 1992-08-26 1993-08-17 E. I. Du Pont De Nemours And Company 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
AU747110B2 (en) * 1998-02-25 2002-05-09 Merck & Co., Inc. Method for decreasing QT dispersion or inhibiting the progression of QT dispersion with an angiotensin II receptor antagonist
NZ555334A (en) * 2004-12-24 2010-05-28 Spinifex Pharm Pty Ltd Method of treatment or prophylaxis of a neuropathic condition using AT2 receptor antagonist
JP5230595B2 (ja) 2006-03-20 2013-07-10 スピニフェクス ファーマシューティカルズ ピーティーワイ リミテッド 炎症性疼痛の治療または予防の方法
ES2560327T3 (es) * 2010-01-19 2016-02-18 Novartis Ag Métodos y composiciones para una velocidad de conducción nerviosa mejorada
NZ605444A (en) * 2010-07-21 2015-06-26 Spinifex Pharm Pty Ltd Salt and solvates of a tetrahydroisoquinoline derivative

Also Published As

Publication number Publication date
AU2011281381B2 (en) 2015-07-16
AU2015238774A1 (en) 2015-10-29
CN105777636A (zh) 2016-07-20
US8927575B2 (en) 2015-01-06
HRP20160540T1 (hr) 2016-06-17
ZA201300169B (en) 2016-03-30
JP2017214415A (ja) 2017-12-07
JP5948326B2 (ja) 2016-07-06
NZ708529A (en) 2016-11-25
ME02407B (me) 2016-09-20
PL2595960T3 (pl) 2016-09-30
CA2803699A1 (en) 2012-01-26
NZ605444A (en) 2015-06-26
DK2595960T3 (en) 2016-05-09
HUE028620T2 (en) 2016-12-28
RS54789B1 (sr) 2016-10-31
EP2595960B1 (en) 2016-02-24
JP2016164178A (ja) 2016-09-08
CN103003244B (zh) 2016-04-20
AU2017203236A1 (en) 2017-06-08
JP2013531057A (ja) 2013-08-01
US20150105422A1 (en) 2015-04-16
US20120022101A1 (en) 2012-01-26
EP2595960A1 (en) 2013-05-29
WO2012010843A1 (en) 2012-01-26
ES2570135T3 (es) 2016-05-17
US20140080865A1 (en) 2014-03-20
CA2803699C (en) 2016-05-31
EP3081557A1 (en) 2016-10-19
HK1224290A1 (en) 2017-08-18
US9162985B2 (en) 2015-10-20
AU2011281381A1 (en) 2013-01-10
SI2595960T1 (sl) 2016-06-30
PT2595960E (pt) 2016-06-02
US8614227B2 (en) 2013-12-24
CN103003244A (zh) 2013-03-27

Similar Documents

Publication Publication Date Title
NO2025034I1 (no) Remdesivir or a pharmaceutically acceptable salt or ester thereof - forlengelse
IL282732A (en) Salt form of a human hi stone methyltransf erase ezh2 inhibitor
SMT201600184B (it) Sale di meglumina di 6-fluoro-3-idrossi-2-pirazincarbossammide
SMT201600072B (it) Sale sodico di 6-fluoro-3-idrossi-2-pirazina carbossammide
NL300963I2 (nl) inotersen of een zout daarvan
NL300900I2 (nl) glecaprevir of een farmaceutisch aanvaardbaar zout of ester daarvan
SMT201500271B (it) Inibitori di neprilisina
DK3178818T3 (da) Pyrazolylquinoxalinkinasehæmmere
SMT201600370B (it) Complessi chelati di oligonucleotidi
SMT201600272B (it) Diidropiridinoni e piperidinoni arilici come inibitori di mgat2
PL3705453T3 (pl) Sól metalu alkalicznego fluorosulfonyloimidu
DK2623507T3 (da) Morpholinonukleinsyrederivat
EP2629616A4 (en) SUBSTITUTED AMINO-TRIAZOLYL-PDE10-HEMMER
IT1398549B1 (it) Silil- derivati di polisaccaridi
EP2667750A4 (en) MERCHANDISER
EE201000070A (et) R?ivaeseme esitlemise meetod
ES1073502Y (es) Jamonero reversible
ITVI20110301A1 (it) Struttura di sale
IT1398645B1 (it) Vetrina espositiva
TH1101003003B (th) สารประกอบไดอะมิโนเฮทเทอโรไซคลิคคาร์บอกซาไมด์
IT1400965B1 (it) Polimorfi di fexofenadina
ES1075251Y (es) Expositor de mercancias
FIU20100474U0 (fi) Huomiomerkki
FI20100072A0 (fi) Uudenlainen formulaatio
UA21933S (uk) Комплект етикеток